Abstract:IL-35 is a critical immunosuppressive cytokine and several studies have identified that rIL-35 therapy is significantly effective in autoimmune diseases. However, physiological factors to induce the secretion of IL-35 or even the conversion of i35-Bregs remain largely unexplored. Our study is aimed to reveal whether B cell activation factor (BAFF), a dichotomous regulator for B cell immune responses, can influence B cells on producing IL-35 and its underlying mechanisms in lupus. To reveal the effect in vitro, splenic MZ & FO B cells were purified from MRL-Faslpr/lpr mice and cultured in the presence of BAFF. Then, the production of IL-12p35 and Ebi3 were detected. We also identified this effect adversely in vivo by intravenous injection of anti-BAFF mAb into MRL-Faslpr/lpr mice. Furthermore,we investigated the underlying mechanisms in vitro, including IL-35–producing B cells subset, related BAFF receptor and potential signaling pathway. Our results in vitro showed that the production of IL-35 in B cells increased significantly with the stimulation of BAFF (20ng/ml) (P<0.05), an effect can’t be abrogated by pre-treating BAFF-induced B cells with anti-BAFFR mAb (P=0.269),and decreased generation of IL-35 in splenic CD19+ B cells was observed when neutralized serum BAFF in vivo. We also observed higher IL-35 production in BAFF-induced MZ B cells compared with FO B cells (P<0.05). Furthermore, the protein level of IL-35 significantly declined when pre-treated B cells with selective inhibitors of total NF-κB and classical NF-κB1 pathway, respectively in the presence of BAFF (P<0.05). In conclusion, we found that BAFF could induce B cells to produce IL-35 in lupus under certain conditions, predominatly from MZ B cells. To some extent, BAFF engendered IL-35 production in B cells through TACI receptor in which classical NF-κB1 pathway may exert an important role. Overall, our research identified an important physiological factor in the induction of B cells IL-35 production in lupus.

Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4

Retinoic Acid Regulates Mouse B‐cell Activation and Differentiation Induced by Engagement of CD40, B‐cell Antigen Receptor and Cytokine IL‐4

Retinoic Acid Regulates Α-Galactosylceramide-mediated B Cell Activation and Differentiation in CD19hi and CD19lo B Cell Subsets (42.9)

Retinoic Acid and Α-Galactosylceramide Differentially Regulate B Cell Activation in Vitro and Augment Antibody Production in Vivo

α-Galatosylceramide and retinoic acid regulate splenic follicular B cell differentiation and antibody production in a CD1d-dependent manner

Retinoic Acid and Α-Galactosylceramide Regulate the Expression of Costimulatory Receptors and Transcription Factors Responsible for B Cell Activation and Differentiation.

α-Galactosylceramide and all trans-retinoic acid work together to promote antigen presentation and antibody production

All-trans-retinoic acid and CD38 ligation differentially regulate CD1d expression and α-galactosylceramide-induced immune responses

Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells.

Vitamin A and Retinoic Acid in the Regulation of B-Cell Development and Antibody Production

Augmentation of Antibody Responses by Retinoic Acid and Costimulatory Molecules

Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells.

All-trans-retinoic Acid and Erk1/2 Signaling Synergistically Regulate the Expression of CD300B in Human Monocytic Cells

Transcription Factor MafB is a Mediator of Retinoic Acid‐induced Monocytic Cell Differentiation

Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction

Retinoic acid regulates germ cell differentiation in mouse embryonic stem cells through a Smad-dependent pathway

038 B Cell-Activating Factor Promotes the Production of IL-35 in B Cells Derived from MRL-Fas Lpr/lpr Mice

[Myeloid-Derived Suppressor Cells Promoted Autologous B Cell Proliferation in Rheumatoid Arthritis].

PPARgamma drives conversion of inducible Tregs by stimulating dendritic cell production of retinoic acid (89.23)

Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF

All-Trans Retinoic Acid Induces CD4+CD25+FOXP3+ Regulatory T Cells by Increasing FOXP3 Demethylation in Systemic Sclerosis CD4+ T Cells.